Velichka Valcheva
Chief Executive OfficerDr. Velichka Valcheva, also known as Villy, M.D., M.Sc., is Chief Executive Officer of GH Research PLC from September 2024. Prior to this, she served as Vice President of Clinical Research and Medical Affairs of GH Research PLC since August 2023. Dr. Valcheva has more than 20 years of experience in various leadership roles, with global exposure in pharmaceutical and biotech companies. Dr. Valcheva served as VP and Head of Medical Affairs International for Albireo from 2020 until 2023, as well as Medical Lead/Monitor FIH study and clinical development from 2022. Prior to this, Dr. Valcheva served as Global Senior Medical Director Oncology - Hepatocellular Carcinoma for Ipsen from 2018 to 2020. Dr. Valcheva holds a Dr. Med. from University of Medicine – Plovdiv, Bulgaria, as well as a Masters in Pharmaceutical Medicine from Trinity College Dublin, Ireland, where she is also a lecturer on the post-graduate course in Pharmaceutical Medicine. Dublin, The University of Dublin.
Positions
- Company NameGH Research PLCStock CodeGHRSPositionChief Executive OfficerColleagues
- FSFlorian SchonhartingCo-Founder & Non-Executive Chairman of the Board
- MHMagnus HalleCo-Founder & MD of Ireland
- JRJulie RyanVice President of Finance
- ACAaron CameronChief Operating Officer
- MFMichael ForerIndependent Vice Chairman
- DHDermot HanleyIndependent Non-Executive Director
- DMDuncan MooreIndependent Non-Executive Director
